J&J 'very confident' in vaccine, eyes quick resolution
Johnson & Johnson remains "very confident" in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday.
Apr 20, 2021
0
4
Johnson & Johnson remains "very confident" in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday.
Apr 20, 2021
0
4
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.
Apr 12, 2021
0
3
Australia's COVID-19 vaccination rollout has hit yet another crossroads. Public confidence has wavered following the federal government's announcement last week that the Pfizer vaccine was the preferred choice for people ...
Apr 12, 2021
0
2
The federal government's recommendation last week that the Pfizer COVID-19 vaccine is now the preferred vaccine for adults under 50 has shaken public confidence in the COVID-19 vaccine rollout.
Apr 12, 2021
0
3
Up to 80 percent of people offered the AstraZeneca COVID-19 vaccine In Sicily refuse it out of fears over its safety, according to the southern Italian region's president Nello Musumeci.
Apr 11, 2021
0
4
New research from the University of Stirling has shown that the suspension of the AstraZeneca COVID-19 vaccination had no effect on the UK general public's intention of getting the vaccination.
Mar 26, 2021
0
2
A US health agency raised concerns Tuesday that AstraZeneca may have included out-of-date information during trials of its COVID-19 vaccine, a day after the company said its drug was highly effective in preventing the disease.
Mar 23, 2021
0
3
France's health regulator recommended Friday that only people aged 55 and over be administered AstraZeneca's COVID-19 vaccine due to reports of blood clots, while giving the green light to resume its use after a brief suspension.
Mar 19, 2021
0
9
The suspension of the AstraZeneca vaccine in several European countries over the past week could fuel skepticism about the shot far beyond their shores, potentially threatening the rollout of a vaccine that is key to the ...
Mar 19, 2021
0
2
At the start of the year, one of the main causes of the EU's slow rollout of COVID-19 vaccines was lower than expected supplies from AstraZeneca. Fast forward a few weeks and the EU's vaccination program still trails far ...
Mar 10, 2021
0
0